Journal of Clinical Gynecology and Obstetrics, ISSN 1927-1271 print, 1927-128X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Gynecol Obstet and Elmer Press Inc
Journal website https://jcgo.elmerpub.com

Original Article

Volume 14, Number 4, December 2025, pages 167-175


Comparative Analysis of Intracervical Dinoprostone Gel and Vaginal Misoprostol for Labor Induction in a Primigravida at Term

Figure

Figure 1.
Figure 1. Flow chart of steps used in prospective interventional study with the maternal and fetal outcomes.

Tables

Table 1. Distribution of Baseline Pre-Induction Data of the Study Population
 
VariablesGroupsNumberMeanStandard deviationP-value
Age (years)Intravaginal misoprostol10023.983.86> 0.46
Dinoprostone gel10023.623.01
Period of gestation (weeks)Intravaginal misoprostol10038.731.09> 0.89
Dinoprostone gel10038.750.97
Bishop scoreIntravaginal misoprostol1004.690.95> 0.17
Dinoprostone gel1004.081.01
Duration of labor (h)Intravaginal misoprostol10012.384.55> 0.10
Dinoprostone gel10015.493.72

 

Table 2. Change in Bishop Score in Two Groups of Modes of Induction
 
Mode of inductionChange in Bishop scoreTotalStatistical test
YesNo
Intravaginal misoprostol99 (99.0%)1 (1.0%)100 (100.0%)χ2 = 6.37
df = 1
P-valve < 0.01
Dinoprostone gel91 (91.0%)9 (9.0%)100 (100.0%)
Total190 (95.0%)10 (5.0%)200 (100.0%)

 

Table 3. Induction to Active Phase of Labor in Two Groups of Modes of Induction
 
Mode of inductionInduction to active phase of laborTotalStatistical test
YesNo
Intravaginal misoprostol75 (75.0%)25 (25.0%)100 (100.0%)χ2 = 0.89
df = 1
P-valve = 0.43
Dinoprostone gel69 (69.0%)31 (31.0%)100 (100.0%)
Total144 (72.0%)56 (28.0%)200 (100.0%)

 

Table 4. Comparison of Efficacy of Intravaginal Misoprostol and Dinoprostone Gel on Various Parameters of Induction of Labor and Apgar Score of Newborns
 
VariablesMode of inductionNMean (h)Standard deviation (h)t-test
Total duration if induction (years)Dinoprostone gel10015.493.72P-value < 0.05
Intravaginal misoprostol10012.384.55
Induction to active phase of labor (h)Dinoprostone gel698.303.82P-value < 0.05
Intravaginal misoprostol746.163.31
Induction to delivery interval (h)Dinoprostone gel10014.063.66P-value < 0.05
Intravaginal misoprostol10010.844.40
Apgar score at 1 minDinoprostone gel1009.700.71P-value < 0.23
Intravaginal misoprostol1009.551.02
Apgar score at 5 minDinoprostone gel1009.980.20P-value < 0.90
Intravaginal misoprostol1009.860.51

 

Table 5. Induction to Delivery Interval Groups in Two Groups of Modes of Induction
 
Mode of inductionInduction to delivery interval groups (h)TotalStatistical test
4 - 1010 - 1616 - 22
Intravaginal misoprostol61 (61.0%)33 (33.0%)6 (6%)100 (100.0%)χ2 = 8.89
df = 2
P-value < 0.01
Dinoprostone gel40 (40.0%)52 (52.0%)8 (8%)100 (100.0%)
Total101 (50.5%)85 (42.5%)14 (7%)200 (100.0%)

 

Table 6. Need for Oxytocin Augmentation in Two Groups of Modes of Induction
 
Mode of inductionNeed for oxytocin augmentationTotalStatistical test
YesNo
Intravaginal misoprostol67 (67.0%)33 (33.0%)100 (100.0%)χ2 = 25.47
df = 1
P-value < 0.001
Dinoprostone gel95 (95.0%)5 (5.0%)100 (100.0%)
Total140 (72.0%)60 (28.0%)200 (100.0%)

 

Table 7. Association of Cesarean Section Rates With the Inducing Agents in Two Groups
 
Mode of inductionMode of deliveryTotalStatistical test
FTNDLSCS
FTND: full-term normal delivery; LSCS: lower segment cesarean section.
Intravaginal misoprostol71 (71.0%)29 (25.0%)100 (100.0%)χ2 = 0.95
df = 1
P-value = 0.87
Dinoprostone gel69 (69.0%)31 (31.0%)100 (100.0%)
Total140 (72.0%)60 (28.0%)200 (100.0%)

 

Table 8. Intrapartum Complications in Two Groups of Modes of Induction
 
Mode of inductionIntrapartum complications (tachysystole)TotalStatistical test
AbsentPresent
Intravaginal misoprostol98 (98.0%)2 (2.0%)100 (100.0%)Fisher’s exact test
P-value = 0.49
Dinoprostone gel100 (95.0%)0 (5.0%)100 (100.0%)
Total198 (99.0%)2 (1.0%)200 (100.0%)

 

Table 9. Postpartum Complications in Two Groups of Modes of Induction
 
Mode of inductionPostpartum complicationsTotalStatistical test
AbsentPresent
Intravaginal misoprostol95 (95.0%)5 (5.0%)100 (100.0%)χ2 = 0
df = 1
P-value = 1
Dinoprostone gel95 (95.0%)5 (5.0%)100 (100.0%)
Total190 (95.0%)10 (5.0%)200 (100.0%)

 

Table 10. Fetal Outcomes at Birth in Two Groups of Modes of Induction
 
Mode of inductionFetal outcomes at birthTotalStatistical test
GoodMorbid
Intravaginal misoprostol82 (82.0%)18 (18.0%)100 (100.0%)χ2 = 1.41
df = 1
P-value = 0.32
Dinoprostone gel88 (88.0%)12 (12.0%)100 (100.0%)
Total170 (85.0%)30 (15.0%)200 (100.0%)